Thalidomide in Pediatric Inflammatory Bowel Diseases.

NCT00720538 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Inflammatory Bowel Diseases
Crohn's Disease
Ulcerative Colitis

Interventions

DRUG: Thalidomide
DRUG: placebo

Sponsor

IRCCS Burlo Garofolo

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]